联邦制药老牌药企焕发新春,三靶点激动剂一鸣惊人(繁体版)

第一上海
21 May

一、老牌药企焕发新春联邦制药(3933.HK)作为一家拥有35年历史的老牌药企,通过持续的创新和转型,在抗生素全产业链布局的基础上,逐步扩展到胰岛素、创新药研发以及动保业务等多个领域。公司不仅在传统抗生素领域占据龙头地位,还积极开发新一代药物,如三靶点激动剂UBT251,展现出强劲的增长潜力。二、核心业务稳健发展联邦制药在抗生素中间体、原料药及制剂三大板块表现突出,尤其是6-APA和阿莫西林等产品...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10